GAS6 expression identifies high-risk adult AML patients: potential implications for therapy
GAS6 expression identifies high-risk adult AML patients: potential implications for therapy
About this item
Full title
Author / Creator
Whitman, S P , Kohlschmidt, J , Maharry, K , Volinia, S , Mrózek, K , Nicolet, D , Schwind, S , Becker, H , Metzeler, K H , Mendler, J H , Eisfeld, A-K , Carroll, A J , Powell, B L , Carter, T H , Baer, M R , Kolitz, J E , Park, I-K , Stone, R M , Caligiuri, M A , Marcucci, G and Bloomfield, C D
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Emerging data demonstrate important roles for the TYRO3/AXL/MERTK receptor tyrosine kinase (TAM RTK) family in diverse cancers. We investigated the prognostic relevance of
GAS6
expression, encoding the common TAM RTK ligand, in 270 adults (
n
=71 aged<60 years;
n
=199 aged ⩾60 years) with
de novo
cytogenetically normal acute...
Alternative Titles
Full title
GAS6 expression identifies high-risk adult AML patients: potential implications for therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4047202
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4047202
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/leu.2013.371
